The Enterprise Value as of April 2026 (TTM) for Bicara Therapeutics Inc. Common Stock (BCAX) is 1.07B

According to Bicara Therapeutics Inc. Common Stock’s latest financial reports and current stock price. The company's current Enterprise Value is 1.07B. This represents a change of 132.10% compared to the average of 461.33M of the last 4 quarters.

Bicara Therapeutics Inc. Common Stock (BCAX) Historical Enterprise Value (quarterly & annually)

How has BCAX Enterprise Value performed in the past?

The mean historical Enterprise Value of Bicara Therapeutics Inc. Common Stock over the last ten years is 868.46M. The current 1.07B Enterprise Value has changed 12.23% with respect to the historical average. Over the past ten years (40 quarters), BCAX's Enterprise Value was at its highest in in the March 2023 quarter at 1.28B. The Enterprise Value was at its lowest in in the June 2023 quarter at 0.

Bicara Therapeutics Inc. Common Stock (BCAX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Bicara Therapeutics Inc. Common Stock Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Bicara Therapeutics Inc. Common Stock (BCAX) Average Enterprise Value

How has BCAX Enterprise Value performed in the past?

The current Enterprise Value of Bicara Therapeutics Inc. Common Stock (BCAX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Bicara Therapeutics Inc. Common Stock (BCAX) Enterprise Value vs. Peers

How is BCAX’s Enterprise Value compared to its peers?

Bicara Therapeutics Inc. Common Stock’s Enterprise Value is greater than Kura Oncology, Inc. (648.03M), greater than Septerna, Inc. (955.96M), greater than EyePoint Pharmaceuticals, Inc. (991.89M), less than ProKidney Corp. (1.09B), greater than Prime Medicine, Inc. (690.74M), less than Tango Therapeutics, Inc. (2.48B), greater than Phathom Pharmaceuticals, Inc. (808.43M), less than Maravai LifeSciences Holdings, Inc. (1.64B), greater than Savara Inc. (989.32M), greater than Fortrea Holdings Inc. (880.76M),

Build a custom stock screener for Bicara Therapeutics Inc. Common Stock (BCAX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Bicara Therapeutics Inc. Common Stock using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Bicara Therapeutics Inc. Common Stock (BCAX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Bicara Therapeutics Inc. Common Stock or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.